This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Maria Wanda Hemmings: Innovator in Neurological Treatments
Introduction
Maria Wanda Hemmings is a prominent inventor based in Bettingen, Switzerland. She has made significant contributions to the field of neurological disorders through her innovative research and patented inventions. With a total of 2 patents, Hemmings is recognized for her groundbreaking work in the medical field.
Latest Patents
Hemmings' latest patents focus on the treatment of neurological disorders using double-stranded RNA (dsRNA) administration. The first patent describes methods to treat neurological disorders by intrathecal injection of an effective amount of dsRNA into a subject in need. This innovative approach aims to inhibit the expression of a target gene, providing a new avenue for treatment. The second patent reiterates the same methods and applications, emphasizing the potential of dsRNA in pharmaceutical compositions for treating neurological conditions.
Career Highlights
Throughout her career, Hemmings has worked with leading companies in the pharmaceutical industry, including Novartis AG and Arrowhead Research Corporation. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical treatments.
Collaborations
Hemmings has collaborated with notable professionals in her field, including Gabriele Dorn and Pamposh Ganju. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of her inventions.
Conclusion
Maria Wanda Hemmings is a trailblazer in the treatment of neurological disorders, with her innovative patents paving the way for future advancements in medicine. Her dedication to research and collaboration continues to inspire others in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
